Lv51
870 积分 2025-10-17 加入
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
18天前
已完结
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
22天前
已关闭
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
22天前
已完结
A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia
1个月前
已完结
Ianalumab plus Eltrombopag in Immune Thrombocytopenia
1个月前
已完结
BCMA-directed CAR-T cell therapy induces durable drug-free remission in refractory primary immune thrombocytopenia
1个月前
已完结
BCMA-CD3 T-cell engager as salvage therapy for multirefractory primary immune thrombocytopenia
1个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
1个月前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
1个月前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
1个月前
已完结
皖公网安备34019202002308
